Emergent BioSolutions (EBS) Accumulated Expenses (2010 - 2026)
Emergent BioSolutions (EBS) posted quarterly Accumulated Expenses of $22.0 million for Q1 2026, down 10.93% year-over-year from $24.7 million in Q1 2025, and down 47.37% quarter-over-quarter from $41.8 million in Q4 2025.
Emergent BioSolutions (EBS) Accumulated Expenses (2010 - 2026) Analysis & Trends
Emergent BioSolutions' Accumulated Expenses history runs 17 years deep, the most recent figure standing at $22.0 million for Q1 2026.
- In Q1 2026, Accumulated Expenses fell 10.93% year-over-year to $22.0 million; the TTM figure through Mar 2026 stood at $22.0 million (down 10.93% YoY), while the FY2025 annual figure was $41.8 million, down 25.49% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $22.0 million, down from $41.8 million in the prior quarter.
- The five-year high for Accumulated Expenses was $74.4 million in Q2 2022, with the low at $13.6 million in Q2 2025.
- The 5-year median for Accumulated Expenses is $31.2 million (2023), against an average of $35.3 million.
- The sharpest annual moves came in 2023 and 2024: Accumulated Expenses soared 112.32% in 2023, then plunged 74.82% in 2024.
- Emergent BioSolutions' Accumulated Expenses stood at $34.9 million in 2022, then jumped by 112.32% to $74.1 million in 2023, then retreated by 24.29% to $56.1 million in 2024, then retreated by 25.49% to $41.8 million in 2025, then slumped by 47.37% to $22.0 million in 2026.
- Business Quant data shows EBS's Accumulated Expenses at $22.0 million in Q1 2026, $41.8 million in Q4 2025, and $13.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.20 Mn |
| Mar 31, 2026 | 22.00 Mn |
| Dec 31, 2025 | 41.80 Mn |
| Sep 30, 2025 | 13.90 Mn |
| Jun 30, 2025 | 13.60 Mn |
| Mar 31, 2025 | 24.70 Mn |
| Dec 31, 2024 | 56.10 Mn |
| Sep 30, 2024 | 16.10 Mn |
| Jun 30, 2024 | 17.20 Mn |
| Mar 31, 2024 | 14.30 Mn |
| Dec 31, 2023 | 74.10 Mn |
| Sep 30, 2023 | 17.00 Mn |
| Jun 30, 2023 | 31.20 Mn |
| Mar 31, 2023 | 56.80 Mn |
| Dec 31, 2022 | 34.90 Mn |
| Sep 30, 2022 | 35.70 Mn |
| Jun 30, 2022 | 74.40 Mn |
| Mar 31, 2022 | 56.40 Mn |
| Dec 31, 2021 | 51.70 Mn |
| Sep 30, 2021 | 73.40 Mn |